Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Sales | 7,360 | 4,906 | 21,555 | 4,908 | 4,043 |
| Cost of Goods | 1,519 | 2,770 | 2,172 | 1,305 | 536 |
| Gross Profit | 5,841 | 2,136 | 19,383 | 3,603 | 3,507 |
| Operating Expenses | 13,322 | 10,626 | 10,164 | 9,634 | 11,876 |
| Operating Income | -6,962 | -7,720 | 9,391 | -5,726 | -7,833 |
| Interest Expense | 0 | 1,034 | 716 | 788 | 853 |
| Other Income | 175 | 120 | 158 | 141 | 138 |
| Pre-tax Income | -6,787 | -8,634 | 8,833 | -6,373 | -8,548 |
| Net Income Continuous | -6,787 | -8,634 | 8,833 | -6,373 | -8,548 |
| Net Income | $-6,787 | $-8,634 | $8,833 | $-6,373 | $-8,548 |
| EPS Basic Total Ops | -0.14 | -0.18 | 0.19 | -0.14 | -0.19 |
| EPS Basic Continuous Ops | -0.14 | -0.17 | 0.19 | -0.14 | -0.19 |
| EPS Diluted Total Ops | -0.14 | -0.18 | 0.19 | -0.14 | -0.19 |
| EPS Diluted Continuous Ops | -0.14 | -0.17 | 0.19 | -0.14 | -0.19 |
| EPS Diluted Before Non-Recurring Items | -0.14 | -0.18 | 0.19 | -0.14 | -0.19 |
| EBITDA(a) | $-6,701 | $-7,473 | $9,638 | $-5,479 | $-7,584 |